In The News
Federal employees could see cheaper prices for prescription drug coverage within the Federal Employee Health Benefits Plan, under legislation introduced recently. The FEHBP Prescription Drug Oversight and Cost Savings Act, introduced by Rep. Stephen Lynch, D-Mass., would strengthen oversight of the program by the Office of Personnel Management, requiring greater transparency and disclosure on prescription drug purchases.
U.S. Rep. Stephen F. Lynch is pushing for a national memorial in Washington, D.C., to honor the men and women in Emergency Medical Services, an idea first proposed by Boston’s own EMS members.
Congressman Lynch introduced H.R. 2175, the Federal Employees Health Benefits Program Prescription Drug Oversight and Cost Savings Act, which would improve federal oversight of the prescription drug benefits available to federal workers, retirees, and their families through the FEHBP and would better ensure that FEHBP enrollees and the American taxpayer are receiving the best prescription drug benefit for their dollar.
Congressman Lynch provided an update from DC at the Hingham Town Meeting.
Congressman Lynch serves as the Ranking Member of the Task Force to Investigate Terrorism Financing and participated in the first hearing surveying global terrorism.
Congressman Lynch and Congressman Jones (R-NC) wrote a letter to the editor of the New York Times regarding the effort to declassify the 28 pages of the 9/11 Joint Inquiry.
Congressman Lynch joined Quincy Mayor Tom Koch to announce a a $5.3 million FEMA grant that will help the City finance a new pumping station to protect West Quincy from severe flooding.
Congressman Lynch discussed his recent Congressional Delegation to South Africa, Zimbabwe, Mozambique, and Nigeria to review embassy security.
The Senate Homeland Security and Governmental Affairs Committee passed the Wounded Warriors Federal Leave Act. Congressman Lynch originally introduced this legislation and it passed the House Committee on Oversight and Government Reform in January.
Congressman Lynch introduced legislation that would require the Securities and Exchange Commission to carry out a pilot study to examine the effect of banning rebates under the current maker-taker system.